- Home
- XPON vs BDRX Comparison
XPON vs BDRX Comparison
Compare XPON & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- BDRX
- Stock Information
- Founded
- XPON 2016
- BDRX 2000
- Country
- XPON United States
- BDRX United Kingdom
- Employees
- XPON N/A
- BDRX N/A
- Industry
- XPON Electronic Components
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- XPON Technology
- BDRX Health Care
- Exchange
- XPON Nasdaq
- BDRX Nasdaq
- Market Cap
- XPON 3.8M
- BDRX 4.3M
- IPO Year
- XPON 2022
- BDRX N/A
- Fundamental
- Price
- XPON $1.85
- BDRX $7.04
- Analyst Decision
- XPON
- BDRX
- Analyst Count
- XPON 0
- BDRX 0
- Target Price
- XPON N/A
- BDRX N/A
- AVG Volume (30 Days)
- XPON 21.1M
- BDRX 34.3K
- Earning Date
- XPON 08-13-2025
- BDRX 09-29-2025
- Dividend Yield
- XPON N/A
- BDRX N/A
- EPS Growth
- XPON N/A
- BDRX N/A
- EPS
- XPON N/A
- BDRX N/A
- Revenue
- XPON $8,414,250.00
- BDRX N/A
- Revenue This Year
- XPON $61.26
- BDRX N/A
- Revenue Next Year
- XPON N/A
- BDRX N/A
- P/E Ratio
- XPON N/A
- BDRX N/A
- Revenue Growth
- XPON 68.33
- BDRX N/A
- 52 Week Low
- XPON $0.60
- BDRX $5.85
- 52 Week High
- XPON $22.81
- BDRX $163.10
- Technical
- Relative Strength Index (RSI)
- XPON 70.99
- BDRX 36.90
- Support Level
- XPON $1.08
- BDRX $6.86
- Resistance Level
- XPON $5.50
- BDRX $7.25
- Average True Range (ATR)
- XPON 0.36
- BDRX 0.54
- MACD
- XPON 0.06
- BDRX 0.03
- Stochastic Oscillator
- XPON 17.42
- BDRX 38.98
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.